Objectives: The aim of this study was to investigate electronic cigarette use in France with a special focus on its relationship with tobacco smoking.
Methods: The 2014 Health Barometer is a telephone survey of 15,635 individuals which provides a status update regarding electronic cigarettes use in France.
Results: In 2014, 25.7 % of 15-75-year-olds had tried e-cigarettes. Among these, 23.4 % were current vapers (6.0 % of 15-75-year-olds). Among vapers, about half were daily vapers (2.9 % of 15-75-year-olds). Smoking prevalence was high among those who vape: 83.1 % were smokers (74.7 % were daily smokers) and 15.0 % were former smokers. Four out of five vapers considered that they had reduced their cigarette consumption through e-cigarette use. Vaping ex-smokers represented 0.9 % of 15-75-year-olds, which are approximately 400,000 people. This figure represents an initial estimate of the number of smokers who have successfully stopped smoking, at least temporarily, thanks to e-cigarettes.
Conclusions: E-cigarettes in France were on the whole used by smokers. The e-cigarette could have helped several hundreds of thousands of individuals to quit smoking, at least temporarily.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00038-015-0773-9 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Differences in the effectiveness of individual-level smoking cessation interventions by socioeconomic status.
Cochrane Database Syst Rev
January 2025
Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Background: People from lower socioeconomic groups are more likely to smoke and less likely to succeed in achieving abstinence, making tobacco smoking a leading driver of health inequalities. Contextual factors affecting subpopulations may moderate the efficacy of individual-level smoking cessation interventions. It is not known whether any intervention performs differently across socioeconomically-diverse populations and contexts.
View Article and Find Full Text PDFImpacto - A single-arm open-label pilot trial of a digital-based integrated smoking cessation program for Spanish-speaking Hispanic individuals who smoke: Development, feasibility, engagement, and clinical outcomes.
J Subst Use Addict Treat
January 2025
Rest of the World, Austin, TX, USA.
Introduction: Hispanic/Latinx (hereafter Hispanic) individuals who smoke have challenges in quitting and a disproportionate risk of smoking-related health problems when compared to the general population. The smoking inequalities among the Hispanic population are influenced by limited treatment access and chronic stress exposure (e.g.
View Article and Find Full Text PDFImpact of smoking on oral mucosa: A cytological and cellular proliferation study.
Tissue Cell
January 2025
Laboratory Medicine Department, Faculty of Applied Medical Science, University of Al Baha, Saudi Arabia. Electronic address:
Background: Cigarette smoking is known to induce various cellular changes and proliferative activities within the oral mucosa. This study compares the effects of smoking on cellular proliferation and cytological alterations using the AgNORs and Pap staining methods.
Methods: We performed statistical analyses to evaluate the mean AgNORs count in smokers and non- smokers.
Effects of Electronic Cigarettes on Periodontal Health: A Systematic Review and Meta-Analysis.
Int Dent J
January 2025
Research and Graduate Studies Department, Mohammed Bin Rashin University of Medicine and Health Sciences, Dubai, UAE. Electronic address:
Objectives: The use of electronic cigarettes "e-cigarettes," or vaping is growing in popularity, especially among adolescents and young adults. While the effects of cigarette smoking on oral health are well-established, the exact impact that e-cigarettes may have on dental tissues is still uncertain. The aim of the current review was to summarize evidence related to the effect of vaping on the periodontal health status of e-cigarette users.
View Article and Find Full Text PDFDownregulation of the Phosphatase PHLPP1 Contributes to NNK-induced Malignant Transformation of Human Bronchial Epithelial Cells (HBECs).
J Biol Chem
January 2025
Key Laboratory of Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University; Wenzhou, Zhejiang 325035, China; Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Wenzhou, Zhejiang 325053, China. Electronic address:
Cigarette smoking (CS) is one of the greatest health concerns, which can cause lung cancer. 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific nitrosamine, and has been well-documented for its carcinogenic activity in both epidemiological and laboratory studies. PH domain leucine-rich repeat protein phosphatase 1 (PHLPP1) and phosphatase and tensin homolog (PTEN) are two well-known phosphatase tumor suppressors that have been reported to be downregulated in human lung cancer tissues.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!